lutathera
advanced accelerator applications - lútetíum (177lu) oxódotreótíð - neuroendocrine tumors - aðrar lækninga geislavirk lyf - lutathera er ætlað fyrir meðferð unresectable eða sjúklingum, framsækin, vel þroskað (g1 og g2), somatostatini viðtaka jákvæð gastroenteropancreatic taugakirtilsuppruna æxli (gep‑netin) hjá fullorðnum.
lutetium (177lu) chloride billev (previously illuzyce)
billev pharma aps - lutetium (177lu) chloride - radionuclide imaging - heilsueyðandi lyf - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.
ceftriaxon fresenius kabi stungulyfs-/innrennslisstofn, lausn 1 g
fresenius kabi ab - ceftriaxonum dínatríum - stungulyfs-/innrennslisstofn, lausn - 1 g
berinert stungulyfs-/innrennslisstofn og leysir, lausn 500 a.e.
csl behring gmbh* - c1-hemill - stungulyfs-/innrennslisstofn og leysir, lausn - 500 a.e.
flúoróúracil accord stungulyf/innrennslislyf, lausn 50 mg/ml
accord healthcare b.v. - fluorouracilum inn - stungulyf/innrennslislyf, lausn - 50 mg/ml
prednisolon actavis tafla 10 mg
actavis group ptc ehf. - prednisolone - tafla - 10 mg
bendamustine accord stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml
accord healthcare b.v. - bendamustinum hýdróklóríð - stofn fyrir innrennslisþykkni, lausn - 2,5 mg/ml
humulin nph kwikpen stungulyf, dreifa í áfylltum lyfjapenna 100 a.e./ml
eli lilly danmark a/s - insulin human - stungulyf, dreifa í áfylltum lyfjapenna - 100 a.e./ml
nebido stungulyf, lausn 1000 mg/ 4 ml
grünenthal gmbh* - testosterone - stungulyf, lausn - 1000 mg/ 4 ml
prednisolon eql pharma tafla 5 mg
eql pharma ab - prednisolonum inn - tafla - 5 mg